Financing

Proceeds from exercises of stock options and other stock issuances

Zimmer Biomet Holdings Proceeds from exercises of stock options and other stock issuances increased by 623.5% to $12.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 26.3%, from $16.70M to $12.30M. Over 4 years (FY 2021 to FY 2025), Proceeds from exercises of stock options and other stock issuances shows a downward trend with a -24.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalHigher is better
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026

How to read this metric

Higher inflows suggest robust employee participation in equity programs, which can be a sign of positive internal sentiment or high compensation utilization.

Detailed definition

This metric captures the cash inflows received from employees and executives exercising stock options or participating i...

Peer comparison

Commonly reported by public companies with significant equity-based compensation structures; often compared against total share-based compensation expense.

Metric ID: financing_proceeds_from_issuance_of_shares_under_incenti_d15335

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$26.20M$25.80M$5.20M$40.50M$4.50M$18.20M$14.90M$36.00M$25.10M$20.70M$19.30M$56.40M$6.60M$18.60M$500.00K$16.70M$400.00K$20.90M$1.70M$12.30M
QoQ Change-1.5%-79.8%+678.8%-88.9%+304.4%-18.1%+141.6%-30.3%-17.5%-6.8%+192.2%-88.3%+181.8%-97.3%>999%-97.6%>999%-91.9%+623.5%
YoY Change-82.8%-29.5%+186.5%-11.1%+457.8%+13.7%+29.5%+56.7%-73.7%-10.1%-97.4%-70.4%-93.9%+12.4%+240.0%-26.3%
Range$400.00K$56.40M
CAGR-14.7%
Avg YoY Growth+31.3%
Median YoY Growth-10.6%

Frequently Asked Questions

What is Zimmer Biomet Holdings's proceeds from exercises of stock options and other stock issuances?
Zimmer Biomet Holdings (ZBH) reported proceeds from exercises of stock options and other stock issuances of $12.30M in Q1 2026.
How has Zimmer Biomet Holdings's proceeds from exercises of stock options and other stock issuances changed year-over-year?
Zimmer Biomet Holdings's proceeds from exercises of stock options and other stock issuances decreased by 26.3% year-over-year, from $16.70M to $12.30M.
What is the long-term trend for Zimmer Biomet Holdings's proceeds from exercises of stock options and other stock issuances?
Over 4 years (2021 to 2025), Zimmer Biomet Holdings's proceeds from exercises of stock options and other stock issuances has grown at a -24.5% compound annual growth rate (CAGR), from $122.50M to $39.70M.
What does proceeds from exercises of stock options and other stock issuances mean?
Cash received from employees buying company stock through incentive plans.